Feasibility Study of Randomizing Patients to Telemedicine Shared Medical Appointments Versus Telemedicine Single Visits for Men With Prostate Cancer on Active Surveillance
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 88
- Locations
- 1
- Primary Endpoint
- accrual number
- Status
- Active, not recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active surveillance when compared with the usual approach of individual telemedicine visits, which involve the participant visiting a doctor on their own. The researchers will compare the telemedicine group and individual visits by measuring on participant satisfaction and quality of life in each type of visit. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer
- •Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2)
- •Clinical T stage ≤T2B
- •Access to a device with Zoom
- •Ability to speak and understand English
Exclusion Criteria
- •Plan to undergo a prostate biopsy at this follow-up visit
Outcomes
Primary Outcomes
accrual number
Time Frame: 1 year
patient satisfaction
Time Frame: 1 week
using MSK Engage portal survey
Secondary Outcomes
- adherence to active surveillance(6 months)